NCT06129604
Pilot Window of Opportunity Trial (POET) No drug interventions treatment 2 recruiting NCT02115477
Lymphedema After Primary Surgery for Endometrial Cancer No drug interventions Not Available Not Available completed NCT04080284
Trial of Maintenance With Niraparib- Uterine Serous Carcinoma No drug interventions treatment 2 recruiting NCT02983279
Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer No drug interventions treatment Not Available completed NCT03902379
Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological Cancer No drug interventions supportive_care Not Available withdrawn NCT00423254
Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer. No drug interventions treatment 1 completed NCT01184053
Trisenox® in Women With Metastatic Endometrial Cancer treatment 2 terminated NCT02017353
Effect of Curcumin Addition to Standard Treatment on Tumour-induced Inflammation in Endometrial Carcinoma No drug interventions treatment 2 completed NCT00756847
Safety Study of XL147 (SAR245408), in Combination With Paclitaxel and Carboplatin in Adults With Solid Tumors treatment 1 completed NCT04257045
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives No drug interventions Not Available Not Available completed NCT03241745
A Study of Nivolumab in Selected Uterine Cancer Patients treatment 2 completed NCT06365905
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding No drug interventions Not Available Not Available recruiting NCT03671811
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy treatment 2 active_not_recruiting NCT02584478
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) treatment 3 active_not_recruiting NCT02025985
Study of KPT-330 (Selinexor) in Female Patients With Advanced Gynaecologic Malignancies treatment 2 completed NCT04830332
Correlation of Peritoneal Fluid CA-125 Levels With Postoperative Tumor Histology No drug interventions diagnostic Not Available completed NCT04152499
Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies treatment 1 / 2 recruiting NCT01273636
Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia No drug interventions Not Available Not Available unknown_status NCT04851119
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors treatment 1 / 2 recruiting NCT02646319
Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations treatment 0 completed NCT02465541
Gentle Yoga and Dietary Counseling in Improving Physical Function and Quality of Life in Stage I-II Endometrial Cancer Survivors No drug interventions supportive_care Not Available completed NCT05712941
Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer treatment 3 withdrawn NCT02611024
Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors treatment 1 / 2 recruiting NCT02506816
Preoperative Olaparib Endometrial Carcinoma Study (POLEN) Not Available Not Available completed NCT04251416
A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma treatment 2 recruiting NCT00791635
Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer No drug interventions Not Available Not Available active_not_recruiting NCT05121363
A Clinical Trial to Evaluate TQB2858 Injection Combined With Anlotinib Hydrochloride Capsule in the Treatment of Recurrent or Metastatic Advanced Endometrial Carcinoma treatment 2 unknown_status NCT00729586
Temsirolimus With or Without Megestrol Acetate and Tamoxifen Citrate in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer treatment 2 completed NCT04716686
Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma treatment 2 recruiting NCT03945786
Diagnostic Performance of Hybrid PET/MRI in the Staging of Endometrial Carcinoma No drug interventions Not Available Not Available suspended NCT03372720
Fractional CO2 Laser Therapy in Minimizing Genitourinary Syndrome of Menopause in Gynecological Cancer Survivors No drug interventions supportive_care Not Available completed NCT00997373
Letrozole as a Treatment of Endometrial Cancer treatment Not Available completed NCT03877627
The Clinical Significance of Sentinel Lymph Node Imaging Combined With Imaging Examination in Pelvic and Peritoneal Lymphadenectomy for Endometrial Carcinoma No drug interventions treatment Not Available unknown_status NCT02465060
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) screening 2 active_not_recruiting NCT06253494
Pembrolizumab, Lenvatinib and IL-15 Superagonist N-803 in Combination With HER2 Targeting Autologous Dendritic Cell (AdHER2DC) Vaccine in Participants With Advanced or Metastatic Endometrial Cancer treatment 1 / 2 recruiting NCT03015129
A Study of Durvalumab With or Without Tremelimumab in Endometrial Cancer treatment 2 completed NCT05086692
A Beta-only IL-2 ImmunoTherapY Study No drug interventions treatment 1 / 2 recruiting NCT06413992
Camrelizumab Plus Fluzoparib for TP-53 Mutated Endometrial Cancer No drug interventions treatment 2 recruiting NCT02807844
Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies No drug interventions treatment 1 / 2 completed NCT01366144
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction No drug interventions treatment 1 active_not_recruiting NCT05059444
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation No drug interventions Not Available Not Available recruiting NCT02628067
Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) No drug interventions treatment 2 recruiting NCT04224467
The Application of Real-Time Near-infrared Imaging in Gynecological Surgery No drug interventions diagnostic Not Available recruiting NCT03076372
A Study Evaluating MM-310 in Patients With Solid Tumors No drug interventions treatment 1 unknown_status NCT03917381
GEN1046 Safety Trial in Patients With Malignant Solid Tumors No drug interventions treatment 1 / 2 active_not_recruiting NCT05036681
A Phase II Study of Futibatinib and Pembrolizumab in Metastatic Microsatellite Stable Endometrial Carcinoma No drug interventions treatment 2 recruiting NCT00334295
Fulvestrant for the Treatment of Recurrent or Metastatic Endometrial Carcinoma. No drug interventions treatment 2 completed NCT02730923
Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA) No drug interventions treatment 1 / 2 active_not_recruiting NCT06502743
First-line Carboplatin and Paclitaxel in Combination With Pembrolizumab, Followed by Maintenance Pembrolizumab With or Without Nesuparib, in Patients With Newly Diagnosed Advanced or Recurrent MMR-proficient (pMMR) Endometrial Cancer No drug interventions treatment 2 not_yet_recruiting NCT05950464
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer No drug interventions treatment 1 recruiting NCT04474184
Development of a New Early Detection Test to Reduce Racial Disparities in Endometrial Cancer (EC) Death Rates No drug interventions screening 1 completed NCT03027479
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss No drug interventions health_services_research Not Available completed NCT05714553
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours No drug interventions treatment 1 / 2 recruiting NCT03752398
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) No drug interventions treatment 1 completed NCT03460483
Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care No drug interventions screening Not Available active_not_recruiting NCT01455493
A Study of GDC-0980 in the Treatment of Recurrent or Persistent Endometrial Carcinoma No drug interventions treatment 2 completed NCT04567771
Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer No drug interventions treatment Not Available recruiting NCT03517488
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors No drug interventions treatment 1 completed NCT05894915
Study and Transformation of Tumor Molecular Features Screening Model of Endometrial Carcinoma Surgical Approach No drug interventions treatment Not Available not_yet_recruiting NCT06102252
Combination Chemotherapy of Paclitaxel and Carboplatin With or Without Anthracycline as Aneo Adjuvant Treatment in Advanced Endometrial Carcinoma No drug interventions treatment Not Available not_yet_recruiting NCT00879359
Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer No drug interventions treatment 2 completed NCT04713618
Changes in Pelvic Health, Sexual Function, and Quality of Life in Women With Pelvic Cancer Undergoing Radiation Therapy No drug interventions Not Available Not Available active_not_recruiting NCT02598219
Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. No drug interventions treatment 3 active_not_recruiting NCT04634617
Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors No drug interventions Not Available Not Available active_not_recruiting NCT05407025
Targeting Inflammation for Endometrial Cancer Prevention No drug interventions Not Available Not Available active_not_recruiting NCT05669430
A Study of GV20-0251 in Patients With Solid Tumor Malignancies No drug interventions treatment 1 recruiting NCT00165126
Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma No drug interventions Not Available Not Available completed NCT00483327
Management of Atypical Endometrial Hyperplasia and Endometrial Carcinoma Using Megestrol Acetate No drug interventions treatment 2 completed NCT04652076
GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or Pembrolizumab No drug interventions treatment 1 / 2 recruiting NCT04178460
A Study of Niraparib Combined With MGD013 in Patients With Advanced or Metastatic Solid Tumor Who Failed Prior Treatment No drug interventions treatment 1 terminated NCT05316467
Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma No drug interventions treatment 2 / 3 recruiting NCT02368067
Improved Method of Detecting Cancer Metastases No drug interventions treatment Not Available unknown_status NCT04576104
Megestrol Acetate Compared With Megestrol Acetate and Metformin to Prevent Endometrial Cancer No drug interventions prevention 2 recruiting NCT05139368
Hypofractionated Radiotherapy for the Treatment of Cervical or Endometrial Cancer No drug interventions treatment Not Available recruiting NCT03849469
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors No drug interventions treatment 1 completed NCT05691010
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer No drug interventions treatment 0 recruiting NCT02977195
First in Human Evaluation of Safety, Pharmacokinetics, and Clinical Activity of a Monoclonal Antibody Targeting Netrin 1 in Patients With Advanced/Metastatic Solid Tumors No drug interventions treatment 1 completed NCT04839614
Concurrent Laparoscopic Hysterectomy and Weight Loss Surgery in Obese Patients With Endometrial Carcinoma or Endometrial Intraepithelial Neoplasia No drug interventions health_services_research Not Available recruiting NCT04678414
Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer No drug interventions Not Available Not Available recruiting NCT04159155
A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer No drug interventions treatment 2 / 3 recruiting NCT03745950
UTOLA: UTerin OLAparib No drug interventions treatment 2 active_not_recruiting NCT02630823
MK-3475 Immunotherapy in Endometrial Carcinoma No drug interventions treatment 1 completed NCT03367923
Health and Recovery Program in Increasing Physical Activity Level in Stage IA-IIIA Endometrial Cancer Survivors No drug interventions supportive_care 2 completed NCT02387645
LUDEC Study - Pilot Study of the Lavage of the Uterine Cavity for the Diagnosis of Endometrial Carcinoma No drug interventions diagnostic Not Available completed